 Premenopause
"Premenopause" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.
| Descriptor ID |
D017697
|
| MeSH Number(s) |
G08.686.157.500.812 G08.686.841.249.500.812
|
| Concept/Terms |
Premenopause- Premenopause
- Premenopausal Period
- Pre-Menopause
- Pre-menopausal Period
- Period, Pre-menopausal
|
Below are MeSH descriptors whose meaning is more general than "Premenopause".
Below are MeSH descriptors whose meaning is more specific than "Premenopause".
This graph shows the total number of publications written about "Premenopause" by people in this website by year, and whether "Premenopause" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 0 | 2 | 2 | | 1998 | 0 | 2 | 2 | | 1999 | 2 | 2 | 4 | | 2000 | 0 | 2 | 2 | | 2002 | 1 | 3 | 4 | | 2003 | 1 | 2 | 3 | | 2004 | 1 | 0 | 1 | | 2005 | 0 | 3 | 3 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 2 | 2 | | 2008 | 3 | 1 | 4 | | 2009 | 1 | 2 | 3 | | 2011 | 1 | 3 | 4 | | 2012 | 0 | 2 | 2 | | 2013 | 1 | 1 | 2 | | 2014 | 1 | 3 | 4 | | 2015 | 0 | 3 | 3 | | 2016 | 0 | 2 | 2 | | 2017 | 0 | 4 | 4 | | 2018 | 2 | 3 | 5 | | 2019 | 0 | 4 | 4 | | 2020 | 1 | 1 | 2 | | 2021 | 1 | 4 | 5 | | 2022 | 0 | 2 | 2 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Premenopause" by people in Profiles.
-
Page CE, Soreth B, Metcalf CA, Johnson RL, Duffy KA, Sammel MD, Loughead J, Epperson CN. Natural vs. surgical postmenopause and psychological symptoms confound the effect of menopause on executive functioning domains of cognitive experience. Maturitas. 2023 Apr; 170:64-73.
-
Grimes NP, Bertone-Johnson ER, Whitcomb BW, Sievert LL, Crawford SL, Gold EB, Avis NE, Greendale GA, Santoro N, Habel LA, Reeves KW. Anti-M?llerian hormone levels and breast cancer risk in the study of women's health across the nation. Cancer Causes Control. 2022 Aug; 33(8):1039-1046.
-
Rodr?guez-Valent?n R, Torres-Mej?a G, Mart?nez-Matsushita L, Angeles-Llerenas A, G?mez-Flores-Ramos L, Wolff RK, Baumgartner KB, Hines LM, Ziv E, Flores-Luna L, S?nchez-Zamorano LM, Ortiz-Panozo E, Slattery ML. Energy homeostasis genes modify the association between serum concentrations of IGF-1 and IGFBP-3 and breast cancer risk. Sci Rep. 2022 02 03; 12(1):1837.
-
Orlando MS, Yao M, Chang OH, Shippey E, Bosko T, Cadish L, Falcone T, Kho RM. Perioperative outcomes in a nationwide sample of patients undergoing surgical treatment of ovarian endometriomas. Fertil Steril. 2022 02; 117(2):444-453.
-
Cole SE, John EM, Hines LM, Phipps AI, Koo J, Ingles SA, Baumgartner KB, Slattery ML, McKean-Cowden R, Wu AH. Cumulative menstrual months and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities Study. Int J Cancer. 2022 01 15; 150(2):208-220.
-
Sukumar JS, Quiroga D, Kassem M, Grimm M, Shinde NV, Appiah L, Palettas M, Stephens J, Gatti-Mays ME, Pariser A, Cherian M, Stover DG, Williams N, Van Deusen J, Wesolowski R, Lustberg M, Ramaswamy B, Sardesai S. Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer. Breast Cancer Res Treat. 2021 Nov; 190(2):183-188.
-
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, S?tersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Borrego MR, Moore HC, Saunders C, Cardoso F, Susnjar S, Bjelic-Radisic V, Smith KL, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O. Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. Breast. 2021 Oct; 59:327-338.
-
Ruz M, Carrasco F, Rojas P, Codoceo J, Inostroza J, Basfi-Fer K, Csendes A, Papapietro K, Pizarro F, Olivares M, Westcott JL, Hambidge KM, Krebs NF. Zinc absorption and zinc status are reduced after either sleeve gastrectomy or Roux-en-Y gastric bypass in premenopausal women with severe obesity studied prospectively over 24 postoperative months. Am J Clin Nutr. 2021 07 01; 114(1):322-329.
-
Gavin KM, Melanson EL, Hildreth KL, Gibbons E, Bessesen DH, Kohrt WM. A Randomized Controlled Trial of Ovarian Suppression in Premenopausal Women: No Change in Free-Living Energy Expenditure. Obesity (Silver Spring). 2020 11; 28(11):2125-2133.
-
Park YM, Jankowski CM, Ozemek C, Hildreth KL, Kohrt WM, Moreau KL. Appendicular lean mass is lower in late compared with early perimenopausal women: potential role of FSH. J Appl Physiol (1985). 2020 05 01; 128(5):1373-1380.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|